Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
14 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
16 Aug 22
NT 10-Q
Notice of late quarterly filing
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
27 Dec 23
8-K
Entry into a Material Definitive Agreement
30 Jun 23
8-K
Entry into a Material Definitive Agreement
2 Jun 23
8-K/A
Changes in Registrant's Certifying Accountant
18 May 23
8-K
Changes in Registrant's Certifying Accountant
17 May 23
8-K
Departure of Directors or Certain Officers
12 Jan 23
8-K
Departure of Directors or Certain Officers
28 Sep 22
8-K
ViCapsys Life Sciences Appoints Federico Pier as Chief Executive Officer
12 Apr 22
8-K/A
Completion of Acquisition or Disposition of Assets
29 Jul 10
8-K
Departure of Directors or Certain Officers
1 Jul 10
Registration and prospectus
D
$330.00 k in equity / debt, sold $330.00 k, 1 investor
13 Jul 23
S-1
IPO registration
3 Jul 23
10-12G/A
Registration of securities (amended)
30 Mar 20
10-12G/A
Registration of securities (amended)
20 Mar 20
10-12G
Registration of securities
12 Feb 20
D
$6M in equity, sold $50K, 3 investors
16 Feb 18
D
Indefinite amount in equity, 52 investors
8 Jan 18
15-15D
Suspension of duty to report
7 Nov 16
D
$1.5M in equity, sold $470K, 17 investors
25 May 10
D
Indefinite amount in equity / options, 4 investors
24 May 10
Other
UPLOAD
Letter from SEC
6 Apr 20
UPLOAD
Letter from SEC
27 Mar 20
CORRESP
Correspondence with SEC
20 Mar 20
UPLOAD
Letter from SEC
11 Mar 20
EFFECT
Notice of effectiveness
9 Dec 09
UPLOAD
Letter from SEC
9 Dec 09
UPLOAD
Letter from SEC
9 Dec 09
CORRESP
Correspondence with SEC
3 Dec 09
CORRESP
Correspondence with SEC
29 Sep 09
UPLOAD
Letter from SEC
11 Aug 09